2 growth shares for ASX investors that like money

If you like making money, Gentrack Group Ltd (ASX: GTK) shares and Pro Medicus Limited (ASX: PME) shares should be on your watchlist.

Who is Gentrack?

I have been banging on about Gentrack for a while now and its share price has flown higher. To be candid, it pains me a little bit — because I didn’t buy any!

Gentrack is a $380 million software business which has developed systems used by airports, energy and water utilities. The UK water market presents a key opportunity for the company in coming years. However, Gentrack’s software can be sold nearly anywhere.

Why software?

If it is done right, developing software is often an underrated investment. Good software should only be written once. And once it is up and running and the program is being sold, new clients come on board with no extra heavy lifting. If the customer gets a good experience from the program they are unlikely to change or develop their own systems, so they accept the yearly price increases and pay what is effectively a subscription to the software company.

For some software companies, like Gentrack, these features can make them a growth and defensive business in one. Gentrack pays a handy 2.4% dividend.

Who is Pro Medicus?

Pro Medicus is a Melbourne-based company that ticks many boxes.

It has developed software that enables doctors and radiologists to send enormous medical images to a smartphone in seconds. It is excellent software and disrupting traditional systems in hospitals around the world. Tick.

The company is growing. Tick.

It has great economics (e.g profit margins). Tick.

Pro Medicus is well run, with many key players in its team having deep experience in their respective fields and a long tenure. Tick.

Management also own lots of their company’s shares, which keeps them incentivised to do well by all shareholders. Tick.

Unfortunately, valuation is where this health technology business falls down.

I suppose it’s the price of being a great business when 90% of the others around you are average.

Foolish Takeaway

Gentrack and Pro Medicus offer good products in attractive industries. However, their shares are not cheap, so we must take a long-term view (five years plus) to enjoy the benefits of these compounding machines.

HOT OFF THE PRESSES: The Motley Fool's #1 Dividend Pick for 2017

With its shares up 90% in just the last five years, this 'under the radar' consumer favourite is both a hot growth stock AND our expert's #1 dividend pick for 2017. Now we're pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is click the link below!

Simply click here to receive your copy of our brand-new FREE report, "The Motley Fool's Top Dividend Stock for 2017."

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes and encourages your feedback. You can follow him on Twitter @OwenRask.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.